Immunization is the most effective strategy to reduce the impact of influenza in our community, as it can prevent or attenuate influenza illness, and reduce mortality, hospitalization, and complications, such as pneumonia. Ottawa Public Health will support your efforts to increase vaccine coverage in your facility by providing information and resources, and by having public health staff available for consultation.
The annual National Advisory Committee on Immunization (NACI) statement
for 2015-2016 is posted on the Public Health Agency of Canada web site. NACI (2015) concludes that “egg allergic individuals may be vaccinated against influenza using TIV, without prior influenza vaccine skin test and with the full dose, irrespective of a past severe reaction to egg.
Vaccine ordering and pick up
Vaccine Distribution Room hours are Monday to Friday, 8 am to 4 pm. NOTE: November 11 is a statutory holiday and the Vaccine Distribution Room will be closed.
- Use the Seasonal Influenza Vaccine Order Form 2015/2016 from Ottawa Public Health, not the MOHLTC form
- Place your order in doses. Orders will be filled in the order they are received, with priority to high-risk groups. Please allow 7-10 business days for your order to be processed.
- Always reserve a small quantity of vaccine for persons age 65 and over, and persons under 65 with medical conditions that put them at high risk for influenza-related complications
- Your facility will be called when your order is ready. Arrange to pick up your order within 48 hours of notification at the Ottawa Public Health Vaccine Program, 100 Constellation Drive.
- Bring your own cooler and ice pack
- Vaccine that is not used by your facility cannot be redistributed. To reduce vaccine wastage, only order the quantity that you are sure to use. You can order more vaccine as needed.
Also available for downloading are:
During the 2015/2016 season, seven different influenza vaccine products will be distributed,
- AGRIFLU® (Novartis), a trivalent vaccine that is supplied in 10-dose vials
- FLUZONE® (Sanofi Pasteur),a quadrivalent vaccine that is supplied in 10-dose vials
- FLUVIRAL® (GSK, Inc.), a trivalent vaccine that is supplied in 10-dose vials\
- FLUAD® (Novartis), an adjuvanted vaccine that is supplied in pre-filled syringes
- FluLaval Tetra® (GSK Inc), a quadrivalent vaccine that is supplied in 10 dose vial
- Influvac® (BGP Pharma Inc), a trivalent vaccine that is supplied in pre-filled syringes
- Flumist® (AstraZeneca Canada), a quadrivalent live attenuated vaccine that is administered intra nasally
Except for the Flumist®, they are all split-virus, inactivated vaccines. They all contain the following antigens:
- B/Phuket/3073/2013-like virus
- B/Brisbane/60/2008-like virus strain (for the quadrivalent only)
Influenza vaccine contraindications and precaution
Consult the product monograph
Report of adverse events following immunization (AEFI)
All adverse events following administration of an influenza vaccine must be reported to Ottawa Public Health within 24 hours by fax to 613-580-9660, attention to Kerry Kennedy using the AEFI form [PDF 200 KB]. If you have any questions related to the reporting of adverse events following immunization, please call 613-580-6744, ext. 23504.
Health care Agencies and workplaces excluding doctors providing influenza vaccine clinics
Immunization is the single most effective means to reduce the impact of influenza, as it can prevent or attenuate influenza illness, reduce complications such as pneumonia, hospitalizations, and mortality.
Ottawa Public Health seeks to support you in your efforts to increase vaccine coverage in your facility by offering information and resources, and by having public health staff available for consultation. For information on the 2015/2016 Seasonal UIIP, please email firstname.lastname@example.org.
Return unused vaccine to the Ottawa Public Health Vaccine Program once your clinics are finished for the season using Ottawa Public Health Vaccine Return Form.
- Ministry of Health and Long-Term Care (MOHLTC)
- Ottawa Public Health Immunization contact information
- Forms and resources
- To order vaccine fax the Influenza vaccine order form to 613-580-2783
- Questions regarding a vaccine order 613-580-6744, ext. 24225 or email email@example.com
- Vaccine-associated adverse events reporting form fax to 613-580-9660, questions 613-580-6744, ext. 19241
- Hospitals, long-term care, retirement homes call the outbreak reporting line 613-580-6744 ext 26325
- Workplaces call Ottawa Public Health Information 613-580-6744, ext. 15414
- Manufacturers’ telephone numbers:
- Sanofi Pasteur (Vaxigrip® and Fluzone®) 1-888-621-1146,
- Novartis (Fluad® and Agriflu®) 1-888-363-8883
- GlaxoSmithKline, Inc. (Fluviral®) and fluLavalTetra® 1-800-387-7374
- BGP Pharma Inc Influvac ® 1-800-699-9948
- AstraZeneca Canada (Flumist®) 1-800-461-3787